Preeminent Pediatric Cancer Physician-Scientist Timothy Cripe Joins Nationwide Childrens Hospital

January 31, 2012

Oncologist and cancer researcher, Timothy P. Cripe, MD, PhD, has been appointed Chief of the Division of Hematology/Oncology and Bone Marrow Transplantation at Nationwide Children’s Hospital. Dr. Cripe will also be a member of the faculty at The Ohio State University College of Medicine.  

Before coming to Nationwide Children’s, Dr. Cripe was Medical Co-Director in the Office for Clinical and Translational Research and is the founding Director of the Comprehensive Musculoskeletal Tumor Program at Cincinnati Children’s Hospital Medical Center. At the University of Cincinnati, he was a Professor of Pediatrics and Director of Pilot and Collaborative Studies in the Center for Clinical and Translational Science and Training. His clinical interests include gene and viral therapies for solid tumors in children, including brain tumors, neuroblastoma, and bone and soft tissue sarcomas. His current research focuses on developing and testing new, targeted therapies for pediatric solid tumors and translating those findings into clinical studies. He also investigates the use of viruses that selectively infect and kill cancer cells, studies their utility for killing cancer stem cells, and was among the first in the country to launch clinical trials of attenuated viruses in children.

Dr. Cripe is a magna cum laude graduate of Princeton University and completed his MD, PhD in genetics and pediatric residency training at the University of Iowa. He was a clinical fellow in pediatric hematology/oncology at the Children's Hospital and the Dana-Farber Cancer Institute in Boston, and a research fellow at the Children's Hospital and University of Colorado Health Sciences Center in Denver. Following his subspecialty training, he was an Assistant Professor of Pediatrics at the University of Wisconsin Children's Hospital and Comprehensive Cancer Center in Madison and was the Pediatric Medical Director of the UW/ American Red Cross Hemophilia Treatment Center.

“By recruiting an outstanding  physician-scientist like Tim Cripe to the Nationwide Children’s clinical and research community, we expand our world class capabilities in understanding and treating pediatric cancer and blood diseases,” said Steve Allen, MD, Nationwide Children’s CEO. “Tim’s leadership as chief of Hematology/Oncology and Bone Marrow Transplantation will enhance our role as an international leader in pediatric research and care.”

NOTE TO EDITOR: Dr. Cripe is a resident of Dublin, OH (43017).

Dr. Timothy Cripe, chief of the Division of Hematology/Oncology and Bone Marrow Transplantation.

About Nationwide Children's Hospital

Named to the Top 10 Honor Roll on U.S. News & World Report’s 2019-20 list of “Best Children’s Hospitals,” Nationwide Children’s Hospital is one of America’s largest not-for-profit freestanding pediatric health care systems providing wellness, preventive, diagnostic, treatment and rehabilitative care for infants, children and adolescents, as well as adult patients with congenital disease. Nationwide Children’s has a staff of more than 13,000 providing state-of-the-art pediatric care during more than 1.5 million patient visits annually. As home to the Department of Pediatrics of The Ohio State University College of Medicine, Nationwide Children’s physicians train the next generation of pediatricians and pediatric specialists. The Abigail Wexner Research Institute at Nationwide Children’s Hospital is one of the Top 10 National Institutes of Health-funded freestanding pediatric research facilities. More information is available at